Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: A survey from Tyrolean hospitals

Author： Waldthaler Christian  

Publisher： Springer Publishing Company

ISSN： 0043-5325

Source： Wiener klinische Wochenschrift, Vol.123, Iss.9-10, 2011-05, pp. : 269-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bendamustine, thalidomide and dexamethasone combination therapy for relapsed/refractory myeloma patients: results of the MUKone randomized dose selection trial

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 336-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 365-373

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS)

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 3, 2015-03 ,pp. : 204-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Use of Psychoactive Drugs in Elderly Patients with Psychiatric Disorders: Survey Conducted in Twelve Veterans Administration Hospitals

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 23, Iss. 3, 1975-03 ,pp. : 104-112

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia

By  

Acta Haematologica, Vol. 136, Iss. 3, 2016-08 ,pp. : 174-177

Karger

Access to resources Recommend Favorite